NAD+: Nicotinamide Adenine Dinucleotide in Research — Overview
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every living cell and required for hundreds of enzymatic reactions essential to life. First discovered in 1906 by Arthur Harden and William John Young during research on fermentation, NAD+ has become one of the most actively studied molecules in aging and longevity research. Its central role in cellular energy production, DNA repair, and gene regulation — combined with the consistent observation that NAD+ levels decline with age across multiple species — has made it a focal point of preclinical investigation into the mechanisms of biological aging.
For a broader overview of peptide and compound science, see our comprehensive guide: What Are Peptides?
What NAD+ Does in Cells
NAD+ is not a peptide in the traditional sense — it is a dinucleotide coenzyme. However, it is included in research peptide catalogs because of its central role in the same biological pathways (cellular repair, longevity, mitochondrial function) that peptide compounds like Epitalon, SS-31, and MOTS-c are studied for. Understanding NAD+ biology is essential context for the broader longevity peptide research category.
NAD+ participates in cellular biology through three primary mechanisms:
Redox reactions (energy production) — NAD+ acts as an electron carrier in glycolysis, the citric acid cycle, and oxidative phosphorylation. It accepts electrons (becoming NADH) and donates them to the electron transport chain, driving ATP synthesis. Without adequate NAD+, cellular energy production is impaired at the most fundamental level.
Sirtuin activation (gene regulation) — Sirtuins (SIRT1–SIRT7) are a family of NAD+-dependent deacetylase enzymes that regulate gene expression, chromatin structure, DNA repair, mitochondrial biogenesis, and stress response. They consume NAD+ as a co-substrate during each deacetylation reaction. When NAD+ levels are low, sirtuin activity is reduced, and their downstream protective functions are compromised.
PARP activity (DNA repair) — Poly(ADP-ribose) polymerase (PARP) enzymes consume NAD+ as a substrate during DNA damage repair. PARP-1 is one of the largest consumers of NAD+ in the cell, and chronic DNA damage (which increases with age) creates sustained NAD+ depletion through PARP activity.
Age-Related NAD+ Decline
One of the most consistent observations in aging research is the decline of NAD+ levels across tissues and species. Published studies have documented this decline in yeast, worms, flies, rodents, and humans. A 2018 review in Cell Metabolism synthesized findings across these model systems and characterized the NAD+ decline as a hallmark of the aging process (PMID: 29514064).
The mechanisms driving age-related NAD+ decline involve both increased consumption and decreased synthesis:
Increased CD38 activity — CD38 is an enzyme that degrades NAD+. Research has shown that CD38 expression and activity increase with age in multiple tissues. A 2016 study published in Cell Metabolism demonstrated that CD38 knockout mice maintained higher NAD+ levels with age and showed improved metabolic function compared to wild-type littermates (PMID: 27304511).
PARP overconsumption — As organisms age, cumulative DNA damage increases, leading to sustained PARP activation and chronic NAD+ consumption. This creates a competition for NAD+ between DNA repair (PARP) and gene regulation (sirtuins), with both pathways compromised when total NAD+ is insufficient.
Decreased NAMPT expression — NAMPT (Nicotinamide Phosphoribosyltransferase) is the rate-limiting enzyme in the NAD+ salvage pathway — the primary route by which cells recycle NAD+ from nicotinamide. Published studies have observed decreased NAMPT expression in aged tissues, reducing the cell's capacity to regenerate NAD+ from nicotinamide.
Chronic inflammation — Age-related chronic low-grade inflammation (sometimes called "inflammaging") activates CD38 and PARP pathways, further accelerating NAD+ depletion. This creates a feedback loop: low NAD+ reduces sirtuin-mediated anti-inflammatory gene regulation, which increases inflammation, which further depletes NAD+.
The NAD+-Sirtuin Axis
The relationship between NAD+ and sirtuins has been a central pillar of aging research since the early 2000s. David Sinclair's laboratory at Harvard Medical School has published extensively on this axis, with studies in yeast, mice, and human cell models examining how NAD+ availability modulates sirtuin activity and downstream aging phenotypes.
Key findings in this research area include:
SIRT1 and metabolic regulation — SIRT1 deacetylates multiple metabolic regulators including PGC-1α (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-κB (inflammation). Studies in rodent models have observed that boosting NAD+ levels through precursor supplementation increased SIRT1 activity and improved metabolic parameters (PMID: 22560220).
SIRT3 and mitochondrial function — SIRT3, localized in the mitochondrial matrix, regulates electron transport chain enzyme acetylation. Research has observed that SIRT3 activity is NAD+-dependent and that reduced SIRT3 function correlates with mitochondrial dysfunction in aged tissues.
Cross-species conservation — The NAD+-sirtuin axis is remarkably conserved across evolution. Sir2 (the yeast sirtuin ortholog) was one of the first longevity genes identified, and its NAD+-dependence has been confirmed in yeast, worms (sir-2.1), flies (dSir2), and mammals (SIRT1–7).
NAD+ Precursors: NMN and NR
Direct NAD+ supplementation faces bioavailability challenges due to the molecule's size and charge, which limit cellular uptake. This has driven research interest in NAD+ precursors — smaller molecules that cells can absorb and convert to NAD+ intracellularly.
NMN (Nicotinamide Mononucleotide) is a direct biosynthetic precursor to NAD+ in the salvage pathway. A 2016 study in Cell Metabolism examined long-term NMN administration in mice and reported dose-dependent increases in NAD+ levels across multiple tissues, alongside improved metabolic parameters in aged mice (PMID: 27732836).
NR (Nicotinamide Riboside) enters the NAD+ biosynthetic pathway through a different route (via the NRK1/NRK2 kinases). Published studies have examined NR's effects on NAD+ repletion in rodent models, with observations of increased hepatic and muscular NAD+ levels following supplementation.
The relative efficacy of NMN versus NR as NAD+ precursors remains an active area of research, with studies examining tissue-specific uptake, conversion efficiency, and downstream functional effects in various model systems.
Published Research — Key Study Summaries
Comprehensive NAD+ and Aging Review (2018)
A landmark review in Cell Metabolism synthesized decades of NAD+ research across multiple model organisms. The authors characterized NAD+ decline as a conserved feature of aging and reviewed evidence for the therapeutic potential of NAD+ repletion strategies in preclinical models (PMID: 29514064).
CD38 and NAD+ Decline (2016)
A study published in Cell Metabolism demonstrated that CD38 is a primary driver of age-related NAD+ decline in mice. CD38 knockout mice maintained higher NAD+ levels with age and exhibited improved mitochondrial function and metabolic health compared to age-matched wild-type controls (PMID: 27304511).
NMN Long-Term Administration (2016)
Research examining 12-month NMN administration in mice reported dose-dependent NAD+ increases across tissues including liver, skeletal muscle, and brown adipose tissue. The study observed improved insulin sensitivity, lipid profiles, and physical activity levels in NMN-treated aged mice compared to controls (PMID: 27732836).
Sirtuin Biology Review (2012)
A review in Nature Reviews Molecular Cell Biology provided a comprehensive overview of sirtuin biochemistry, NAD+ dependence, and the evidence linking sirtuin activity to longevity across model organisms. The review discussed both genetic overexpression studies and pharmacological sirtuin activation approaches (PMID: 22560220).
Relationship to Other Longevity Compounds
NAD+ research intersects with several other longevity peptide categories available at CALM Peptides:
Epitalon is studied for telomerase regulation — a distinct but potentially complementary pathway to NAD+-sirtuin-mediated maintenance. See: Epitalon → (coming soon)
SS-31 targets mitochondrial efficiency through cardiolipin binding, addressing the organelle-level consequences of NAD+ depletion. See: SS-31 → (coming soon)
MOTS-c is a mitochondria-derived peptide involved in metabolic homeostasis — pathways that overlap with NAD+-dependent energy regulation. See: MOTS-c → (coming soon)
Purity and Quality Considerations
NAD+ and its precursors are hygroscopic (they readily absorb moisture from the air), which makes proper handling and storage particularly important. Moisture exposure can degrade the compound and reduce effective purity. Lyophilized NAD+ products should be sealed immediately after each use.
Research-grade NAD+ should meet the following minimum specifications:
- Purity: ≥98% as measured by HPLC
- Identity: Confirmed by mass spectrometry (expected MW ~663.43 Da for NAD+)
- Appearance: White to off-white hygroscopic powder
- Documentation: Certificate of Analysis with HPLC and MS data
View CALM Peptides' quality and testing standards →
Available for Research
CALM Peptides offers research-grade NAD+ with Certificates of Analysis available upon request. All products are verified by HPLC and mass spectrometry.
For research use only. Not for human consumption.
Frequently Asked Questions
What is NAD+?
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell. It plays essential roles in cellular energy production, DNA repair, and gene regulation. NAD+ levels have been observed to decline with age across multiple model organisms.
Why do NAD+ levels decline with age?
Research suggests NAD+ decline results from both increased consumption and decreased synthesis. The enzyme CD38 increases in activity with age, PARP enzymes consume more NAD+ due to accumulated DNA damage, and the biosynthetic pathways that produce NAD+ become less efficient.
What are sirtuins and how do they relate to NAD+?
Sirtuins are a family of seven NAD+-dependent deacetylase enzymes (SIRT1–SIRT7) that regulate gene expression, DNA repair, mitochondrial function, and stress response. They require NAD+ as a co-substrate to function.
What is the difference between NAD+, NMN, and NR?
NAD+ is the active coenzyme itself. NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are biosynthetic precursors that cells can convert into NAD+. Each has distinct pharmacokinetic properties and cellular uptake mechanisms.
How should NAD+ research compounds be stored?
Lyophilized NAD+ should be stored at -20°C or colder, sealed and protected from moisture and light. NAD+ is hygroscopic, making proper sealing especially important. Reconstituted solutions should be refrigerated and used promptly.
The information presented in this article is for educational and informational purposes only and is not intended as medical advice. All products referenced are sold as research chemicals for laboratory use only. They are not intended for human consumption and should not be used to diagnose, treat, cure, or prevent any disease. All references to published research are provided for informational context. Consult qualified professionals for guidance related to any health condition.